BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7192830)

  • 1. Altered polyamine excretion in Duchenne muscular dystrophy.
    Russell DH; Stern LZ
    Neurology; 1981 Jan; 31(1):80-3. PubMed ID: 7192830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine excretion in the urine of cancer patients.
    Dreyfuss F; Chayen R; Dreyfuss G; Dvir R; Ratan J
    Isr J Med Sci; 1975 Aug; 11(8):785-95. PubMed ID: 1165175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
    Rudman D; Kutner MH; Chawla RK; Goldsmith MA
    J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamines as markers of response and disease activity in cancer chemotherapy.
    Durie BG; Salmon SE; Russell DH
    Cancer Res; 1977 Jan; 37(1):214-21. PubMed ID: 830407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and urine polyamines in normal and in short children.
    Rudman D; Kutner MH; Chawla RK; Goldsmith MA; Blackston RD; Bain R
    J Clin Invest; 1979 Dec; 64(6):1661-8. PubMed ID: 500832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary polyamine excretion during growth and regression of 1,12-dimethylbenz[a]anthracene-induced rat mammary carcinoma.
    Anehus S; Albinsson A; Andersson G; Heby O
    J Natl Cancer Inst; 1981 Dec; 67(6):1265-8. PubMed ID: 6796745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of polyamines in urine of normal human and cancer patients by capillary gas chromatography.
    Jiang XC
    Biomed Chromatogr; 1990 Mar; 4(2):73-7. PubMed ID: 2350602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered polyamine metabolism in cystic fibrosis.
    Russell DH; Rosenblum MG; Beckerman RC; Durie BG; Taussig LM; Barnett DR
    Pediatr Res; 1979 Oct; 13(10):1137-40. PubMed ID: 503640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis.
    Proctor MS; Wilkinson DI; Orenberg EK; Farber EM
    Arch Dermatol; 1979 Aug; 115(8):945-9. PubMed ID: 464623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary polyamines before and after treatment of malignant tumors].
    Martinović S; Filipović D
    Srp Arh Celok Lek; 1989; 117(7-8):465-71. PubMed ID: 2595471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary putrescine, spermidine, and spermine in human blood and solid cancers and in an experimental gastric tumor of rats.
    Fujita K; Nagatsu T; Maruta K; Ito M; Senba H
    Cancer Res; 1976 Apr; 36(4):1320-4. PubMed ID: 1260758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic determination of polyamines. Polyamines as biochemical markers for cancer.
    Tsuchiya H; Takagi N
    Gifu Shika Gakkai Zasshi; 1983 Feb; 10(2):426-40. PubMed ID: 6576050
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of polyamines: importance of circadian rhythm, age, sex, menstrual cycle, weight, and creatinine excretion.
    Pöyhönen MJ; Uusitalo UM; Kari A; Takala JA; Alakuijala LA; Eloranta TO
    Am J Clin Nutr; 1990 Oct; 52(4):746-51. PubMed ID: 2403068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary polyamine excretion in man. II. Influence of menstrual cycle.
    Beninati S; Accardi L; Spinedi A; Piacentini M
    Biomedicine; 1980; 33(6):182-4. PubMed ID: 7213918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative measurements of urinary polyamines in early morning and 24-hour urine specimens.
    Shinpo K; Fujita K; Maruta K; Teradaira R; Nagatsu T
    Clin Chim Acta; 1983 Jun; 131(1-2):143-8. PubMed ID: 6684002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythmicity of polyamine urinary excretion.
    Hrushesky WJ; Merdink J; Abdel-Monem MM
    Cancer Res; 1983 Aug; 43(8):3944-7. PubMed ID: 6861156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of polyamines by patients with advanced malignancy.
    Waalkes TP; Gehrke CW; Tormey DC; Zumwalt RW; Hueser JN; Kuo KC; Lakings DB; Ahmann DL; Moertel CG
    Cancer Chemother Rep; 1975; 59(6):1103-16. PubMed ID: 1222394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for the use of polyamines as biochemical markers for malignant tumors.
    Horn Y; Beal SL; Walach N; Lubich WP; Spigel L; Marton LJ
    Cancer Res; 1982 Aug; 42(8):3248-51. PubMed ID: 7093963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamines and polyamine complexes: analytical comments.
    Bartos D; Bartos F; Campbell RA
    Physiol Chem Phys; 1980; 12(5):473-80. PubMed ID: 7208641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.